TABLE 3.
Proportions and numbers of transfusion of blood products. Presented as n (%)
| Country |
BE n = 59 |
DK n = 27 |
FI n = 56 |
FR n = 75 |
UK n = 173 |
IT n = 301 |
NL n = 59 |
SK n = 73 |
SE n = 26 |
Total n = 849 |
|---|---|---|---|---|---|---|---|---|---|---|
| Women without PAS | ||||||||||
| Erythrocytes | 38 (69) | 25 (93) | 54 (100) | 69 (96) | 166 (98) | 251 (83) | 58 (98) | 65 (89) | 26 (100) | 752 (90) |
| Median, n (IQR) | 4 (0–8) | 15 (9–22) | 12 (8.75–18) | 8 (5.25–10.75) | 11 (7–18) | 4 (2–6) | 16 (11–24) | N/R | 11.5 (9–18.25) | 7 (4–12) |
| Missing | 4 (7) | 0 (0) | 2 (4) | 3 (4) | 3 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 12 (1) |
| Fresh frozen plasma | 40 (74) | 24 (89) | 48 (100) | 62 (87) | 137 (81) | 157 (52) | 45 (85) | 41 (56) | 21 (91) | 575 (70) |
| Median, n (IQR) | 2 (0–5.25) | 8 (4–14) | 8 (4.25–13.5) | 6 (4–9) | 4 (2–6) | 1 (0–3) | 6 (3–10) | N/R | 6 (2–15) | 4 (0–6) |
| Missing | 5 (9) | 0 (0) | 8 (14) | 4 (5) | 3 (2) | 0 (0) | 6 (10) | 0 (0) | 3 (12) | 29 (3) |
| Thrombocytes | 25 (50) | 24 (89) | 38 (75) | 27 (39) | 76 (45) | 39 (13) | 38 (68) | 41 (57) | 16 (67) | 324 (39) |
| Median, n (IQR) | 0 (0–2) | 3 (2–5) | 16 (0–24) | 0 (0–1) | 0 (0–2) | 0 (0–0) | 2 (0–2) | N/R | 1 (0–2) | 0 (0–2) |
| Missing | 9 (15) | 0 (0) | 5 (9) | 5 (7) | 3 (2) | 0 (0) | 3 (5) | 0 (0) | 2 (8) | 27 (3) |
| Country |
BE n = 14 |
DK n = 17 |
FI n = 16 |
FR n = 23 |
UK n = 103 |
IT n = 188 |
NL n = 36 |
SK n = 30 |
SE n = 26 |
Total n = 453 |
|---|---|---|---|---|---|---|---|---|---|---|
| Women with PAS | ||||||||||
| Erythrocytes | 8 (62) | 14 (82) | 15 (100) | 22 (96) | 100 (97) | 157 (84) | 35 (97) | 25 (83) | 23 (89) | 399 (89) |
| Median, n (IQR) | 4 (0–13.5) | 13 (4.5–21.5) | 12 (6–19) | 8 (5–10) | 10 (6–16) | 3 (2–4) | 11 (5.25–16) | N/R | 7 (2–17) | 5 (2–10) |
| Missing | 1 (7) | 0 (0) | 1 (6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (0.4) |
| Fresh frozen plasma | 10 (77) | 13 (77) | 11 (100) | 22 (96) | 73 (71) | 69 (37) | 27 (79) | 22 (73) | 17 (65) | 264 (59) |
| Median, n (IQR) | 3.5 (0.75–10) | 8 (0.5–15) | 8 (6–11) | 4 (3–7) | 4 (0–6) | 0 (0–2) | 3.5 (2–6.25) | N/R | 4 (0–9) | 2 (0–9.25) |
| Missing | 1 (7) | 0 (0) | 5 (31) | 0 (0) | 0 (0) | 0 (0) | 2 (5.6) | 0 (0) | 0 (0) | 8 (2) |
| Thrombocytes | 6 (46) | 13 (77) | 8 (53) | 10 (44) | 43 (42) | 10 (5) | 13 (38) | 22 (73) | 11 (44) | 136 (30) |
| Median, n (IQR) | 1 (0–5.5) | 2 (1–5.5) | 8 (0–24) | 0 (0–2) | 0 (0–2) | 0 (0–0) | 0 (0–1) | N/R | 0 (0–2) | 0 (0–1.5) |
| Missing | 1 (7) | 0 (0) | 1 (7) | 0 (0) | 0 (0) | 0 (0) | 2 (6) | 0 (0) | 1 (4) | 5 (1) |
BE, Belgium; DK, Denmark; FI, Finland; FR, France; UK, United Kingdom; IT, Italy; NL, The Netherlands; SK, Slovakia; SE, Sweden; IQR, interquartile range.